Regarding the role in inflammatory-based diseases, FPR1 promotes malignant glioblastoma progression [2] and FPR2/ALX is implicated in the pathogenesis of Alzheimer’s disease [3], wound healing, diabetes, obesity and AIDS [4]. Here, FPR2 is linked to obesity due to melanocortin 4 receptor deficiency.